BRPI0216033B8 - "terapia de imunização à base de peptídio para tratamento de arteriosclerose" - Google Patents

"terapia de imunização à base de peptídio para tratamento de arteriosclerose"

Info

Publication number
BRPI0216033B8
BRPI0216033B8 BRPI0216033A BR0216033A BRPI0216033B8 BR PI0216033 B8 BRPI0216033 B8 BR PI0216033B8 BR PI0216033 A BRPI0216033 A BR PI0216033A BR 0216033 A BR0216033 A BR 0216033A BR PI0216033 B8 BRPI0216033 B8 BR PI0216033B8
Authority
BR
Brazil
Prior art keywords
peptide
treatment
arteriosclerosis
immunization therapy
cardiovascular diseases
Prior art date
Application number
BRPI0216033A
Other languages
English (en)
Other versions
BRPI0216033B1 (pt
Inventor
Jan Nilsson
K Shah Prediman
Original Assignee
CardioVax LLC
Cedars Sinai Medical Center
Forskarpatent I Syd Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0101232A external-priority patent/SE0101232D0/xx
Priority claimed from SE0103754A external-priority patent/SE0103754L/xx
Application filed by CardioVax LLC, Cedars Sinai Medical Center, Forskarpatent I Syd Ab filed Critical CardioVax LLC
Publication of BRPI0216033B1 publication Critical patent/BRPI0216033B1/pt
Publication of BRPI0216033B8 publication Critical patent/BRPI0216033B8/pt

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

terapia de imunizaçao a base de peptídio para tratamento de arteriosclerose e desenvolvimento de ensaio a base de peptídio para determinaçao de respostas imunes contra lipoproteina oxidada de baixa densidade. a presente invenção se refere a fragmentos de apoliproteina b, em particular a peptídios definidos dos mesmos, para imunização ou tratamento terapêutico de mamíferos, incluindo seres humanos, contra doenças cardiovasculares isquêmicas, assim como para diagnosticar a presença ou ausência de anticorpos correlacionados ao aumento ou redução de risco de desenvolvimento de doenças cardiovasculares isquêmicas, usando um ou mais dos peptídios em um ensaio elisa (enzyme linked immuno sorbent assay).
BRPI0216033A 2001-04-05 2002-04-05 "terapia de imunização à base de peptídio para tratamento de arteriosclerose" BRPI0216033B8 (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
SE0101232-7 2001-04-05
SE0101232A SE0101232D0 (sv) 2001-04-05 2001-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density liprotein
SE0103754-8 2001-11-09
SE0103754A SE0103754L (sv) 2001-04-05 2001-11-09 Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
BRPI0208685 2002-04-05
PCT/SE2002/000679 WO2002080954A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein

Publications (2)

Publication Number Publication Date
BRPI0216033B1 BRPI0216033B1 (pt) 2018-01-02
BRPI0216033B8 true BRPI0216033B8 (pt) 2021-05-25

Family

ID=62529384

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0216049A BRPI0216049B8 (pt) 2001-04-05 2002-04-05 "terapia de imunização à base de peptídeo para tratamento de arteriosclerose"
BRPI0216033A BRPI0216033B8 (pt) 2001-04-05 2002-04-05 "terapia de imunização à base de peptídio para tratamento de arteriosclerose"

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0216049A BRPI0216049B8 (pt) 2001-04-05 2002-04-05 "terapia de imunização à base de peptídeo para tratamento de arteriosclerose"

Country Status (1)

Country Link
BR (2) BRPI0216049B8 (pt)

Also Published As

Publication number Publication date
BRPI0216033B1 (pt) 2018-01-02
BRPI0216049B1 (pt) 2018-01-02
BRPI0216049B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
BR0208685A (pt) Terapia de imunização à base de peptìdio para tratamento de arteriosclerose e desenvolvimento de ensaio à base de peptìdio para determinação de respostas imunes contra lipoproteìna oxidada de baixa densidade
ECSP024409A (es) Anticuerpos de especificidad doble y metodos para la elaboracion y el uso de los mismos
AT500379B8 (de) Tau-proteine
Rendón-Gandarilla et al. The TvLEGU‐1, a legumain‐like cysteine proteinase, plays a key role in Trichomonas vaginalis cytoadherence
ATE419872T1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
CY1117387T1 (el) ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ
EA200801071A1 (ru) Способы и композиции для применения в целях лечения пациентов с положительным по аутоантителам заболеванием
BR0207283A (pt) Anticorpos anti-egfr modificados com imunogenicidade reduzida
Tian et al. Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease
DK0858504T3 (da) Diagnostiske midler mod og behandlinger af periodontale sygdomme
Zhang et al. Immunization with heat shock protein A and γ-glutamyl transpeptidase induces reduction on the Helicobacter pylori colonization in mice
EA200400134A1 (ru) Терапевтический агент
SE0302312D0 (sv) Peptide-based passive immunization therapy for treatment of atherosclerosis
Fritsché et al. IgE-mediated rat mast cell triggering with tryptic and synthetic peptides of bovine β-lactoglobulin
BRPI0414688A (pt) tratamento de doença respiratória com anti-receptor de il-2
BRPI0216033B8 (pt) "terapia de imunização à base de peptídio para tratamento de arteriosclerose"
EP1534753A4 (en) ANTIBODY PEG POSITION SISOMERS, COMPOSITIONS CONTAINING THEM AND USE THEREOF
EP1495056A4 (en) ANTIBODY DISULFIDISOMERS, THEIR USE AND METHOD FOR THEIR ANALYSIS
ATE245661T1 (de) Natürliche menschliche igm antikörper
Kambayashi et al. Preparation and characterization of a polyclonal antibody against brominated protein
Kim et al. Secretome analysis of host cells infected with Toxoplasma gondii after treatment of human epidermal growth factor receptor 2/4 inhibitors
Loureiro et al. Properties of cryptic epitopes and their corresponding antibodies as indicated by the study of human and ovine growth hormones
SE0104354D0 (sv) Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based ELISA for determination of immune responses against oxidized low-density lipoprotein
WO2004035003A3 (en) Therapeutic adjuvant
BR9908374A (pt) Composição

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A(S) 7A ANUIDADE(S).

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2108 DE 31/05/2011.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: CARDIOVAX, LLC (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/04/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 05/04/2022